An estimated 3.2 million persons in the United States have chronic infection with hepatitis C
virus (HCV)(1). Most new HCV transmissions occur among persons who inject drugs (2) …

Abstract Background/Aim In the era of direct‐acting antivirals (DAA), active screening for
hidden hepatitis C virus (HCV) infection is important for HCV elimination. This study …

In just five years, hepatitis C has changed from a difficult-to-treat chronic condition to one
that is readily cured by a short course of medication. Medical breakthroughs have now …

Abstract Background and Objective Recent advances in hepatitis C virus (HCV) diagnostic
testing methods allow for a one-stop simplified 'test and cure'approach. The cost …

Abstract Background and Aims: Approximately half of adults with hepatitis C in the United
States do not know their infection status, and the majority of persons who know they are …

Objective: To evaluate the cost-effectiveness of different screening patterns for active chronic
hepatitis C virus (HCV) infections utilizing the hepatitis C core antigen test compared to …

Abstract Objectives Hepatitis C virus (HCV) affects 58 million worldwide and> 79% of people
remain undiagnosed. Rapid diagnostic tests (RDTs) for HCV can help improve diagnosis …

Background: Few countries have implemented the necessary policy changes to reduce the
number of steps in the cascade of care to achieve hepatitis C virus (HCV) elimination …

Abstract Background. Hepatitis C virus (HCV) is the most common chronic blood-borne
infection in the United States and will become an increasing source of morbidity and …

Given the growing hepatitis C virus (HCV) epidemic in the United States, it is imperative to
implement a coordinated, equitable public health approach to HCV testing that will facilitate …